Subjective memory complaints in preclinical autosomal dominant Alzheimer disease

被引:21
|
作者
Norton, Daniel J. [1 ,2 ]
Amariglio, Rebecca [1 ,2 ,3 ]
Protas, Hillary [4 ]
Chen, Kewei [4 ]
Aguirre-Acevedo, Daniel C. [5 ]
Pulsifer, Brendan [1 ]
Castrillon, Gabriel [6 ]
Tirado, Victoria [5 ]
Munoz, Claudia [5 ]
Tariot, Pierre [4 ]
Langbaum, Jessica B. [4 ]
Reiman, Eric M. [4 ]
Lopera, Francisco [5 ]
Sperling, Reisa A. [1 ,2 ,3 ]
Quiroz, Yakeel T. [1 ,2 ,5 ,7 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA
[4] Banner Alzheimers Inst, Phoenix, AZ USA
[5] Univ Antioquia, Grp Neurociencias, Medellin, Colombia
[6] Inst Alta Tecnol Med, Medellin, Colombia
[7] Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02129 USA
关键词
COGNITIVE DECLINE; FUTURE DEMENTIA; OLDER-ADULTS; ASSOCIATION; PEOPLE; SELF;
D O I
10.1212/WNL.0000000000004533
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To cross-sectionally study subjective memory complaints (SMC) in autosomal dominant Alzheimer disease (ADAD). Methods: We examined self-reported and study partner-based SMC in 52 young, cognitively unimpaired individuals from a Colombian kindred with early-onset ADAD. Twenty-six carried the PSEN-1 E280A mutation, averaging 7 years of age younger than the kindred's expected clinical onset. Twenty-six were age-matched noncarriers. Participants also underwent structural MRI and cognitive testing. Results: Self-reported SMC were greater in carriers than noncarriers (p = 0.02). Study partner-based SMC did not differ between groups (p = 0.21), but in carriers increased with age (r = 0.66, p < 0.001) and decreased with hippocampal volume (r = -20.35, p = 0.08). Conclusions: Cognitively unimpaired PSEN-1 carriers have elevated SMC. Self-reported SMC may be a relatively early indicator of preclinical AD, while partner-reported SMC increases later in preclinical AD, closer to clinical onset.
引用
收藏
页码:1464 / 1470
页数:7
相关论文
共 50 条
  • [21] Alzheimer disease: Autosomal dominant forms
    Guyant-Marechal, L.
    Campion, D.
    Hannequin, D.
    REVUE NEUROLOGIQUE, 2009, 165 (03) : 223 - 231
  • [22] Subjective memory complaints of family members of patients with Alzheimer's disease and depression
    Heun, R
    Kockler, M
    Ptok, U
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 16 (02) : 78 - 83
  • [23] Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease
    Mueller, Stephan
    Preische, Oliver
    Sohrabi, Hamid R.
    Graeber, Susanne
    Jucker, Mathias
    Dietzsch, Janko
    Ringman, John M.
    Martins, Ralph N.
    McDade, Eric
    Schofield, Peter R.
    Ghetti, Bernardino
    Rossor, Martin
    Graff-Radford, Neill R.
    Levin, Johannes
    Galasko, Douglas
    Quaid, Kimberly A.
    Salloway, Stephen
    Xiong, Chengjie
    Benzinger, Tammie
    Buckles, Virginia
    Masters, Colin L.
    Sperling, Reisa
    Bateman, Randall J.
    Morris, John C.
    Laske, Christoph
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Subjective memory complaints as a predictor of mild cognitive impairment and Alzheimer's disease
    Warren, Samuel L.
    Reid, Edwina
    Whitfield, Paige
    Moustafa, Ahmed A.
    DISCOVER PSYCHOLOGY, 2022, 2 (01):
  • [25] Are subjective cognitive complaints relevant in preclinical Alzheimer's disease? A review and guidelines for healthcare professionals
    Mark, Ruth E.
    Sitskoorn, Margriet M.
    REVIEWS IN CLINICAL GERONTOLOGY, 2013, 23 (01) : 61 - 74
  • [26] Preclinical CSF proteomic changes: a milestone in biomarker detection for autosomal dominant Alzheimer's disease
    Ross, J. Alexander
    Dodel, Richard
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [27] Associations between Metamemory and Markers of Brain Pathology in Preclinical Autosomal Dominant Alzheimer's Disease
    Chaudhry, T.
    Vannini, P.
    Norton, D. J.
    Guzman-Velez, E.
    Baena, A.
    Lopera, F.
    Sperling, R.
    Quiroz, Y. T.
    CLINICAL NEUROPSYCHOLOGIST, 2017, 31 (04) : 715 - 715
  • [28] Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset
    Wang, Guoqiao
    Coble, Dean
    McDade, Eric M.
    Hassenstab, Jason
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Bateman, Randall J.
    Morris, John C.
    Xiong, Chengjie
    ALZHEIMERS & DEMENTIA, 2019, 15 (04) : 506 - 514
  • [29] Autosomal dominant Alzheimer disease: a unique resource to study CSF biomarker changes in preclinical AD
    Schindler, Suzanne Elizabeth
    Fagan, Anne M.
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [30] BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease
    Lim, Yen Ying
    Hassenstab, Jason
    Cruchaga, Carlos
    Goate, Alison
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Maruff, Paul
    Snyder, Peter J.
    Masters, Colin L.
    Allegri, Ricardo
    Chhatwal, Jasmeer
    Farlow, Martin R.
    Graff-Radford, Neill R.
    Laske, Christoph
    Levin, Johannes
    McDade, Eric
    Ringman, John M.
    Rossor, Martin
    Salloway, Stephen
    Schofield, Peter R.
    Holtzman, David M.
    Morris, John C.
    Bateman, Randall J.
    BRAIN, 2016, 139 : 2766 - 2777